David W. Porter

2.5k total citations
63 papers, 1.9k citations indexed

About

David W. Porter is a scholar working on Molecular Biology, Organic Chemistry and Control and Systems Engineering. According to data from OpenAlex, David W. Porter has authored 63 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Organic Chemistry and 8 papers in Control and Systems Engineering. Recurrent topics in David W. Porter's work include Diabetes Treatment and Management (6 papers), Pancreatic function and diabetes (6 papers) and Malaria Research and Control (6 papers). David W. Porter is often cited by papers focused on Diabetes Treatment and Management (6 papers), Pancreatic function and diabetes (6 papers) and Malaria Research and Control (6 papers). David W. Porter collaborates with scholars based in United Kingdom, United States and Switzerland. David W. Porter's co-authors include Victor A. Gault, Christian Hölscher, Peter R. Flatt, A.N. Michel, Stacey F. Bent, Nigel Irwin, Paul C. McIntyre, Steven Patterson, Barry D. Kerr and Adrian V. S. Hill and has published in prestigious journals such as Applied Physics Letters, PLoS ONE and The Journal of Physical Chemistry B.

In The Last Decade

David W. Porter

60 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David W. Porter United Kingdom	27	442	343	268	254	235	63	1.9k
Koji Kobayashi Japan	33	509 1.2×	227 0.7×	399 1.5×	171 0.7×	111 0.5×	229	3.8k
Elliot M. Landaw United States	32	1.2k 2.7×	421 1.2×	53 0.2×	265 1.0×	51 0.2×	76	3.1k
W. Namkung South Korea	36	2.2k 5.1×	85 0.2×	464 1.7×	387 1.5×	346 1.5×	217	4.9k
Seiichi Tanaka Japan	24	352 0.8×	251 0.7×	179 0.7×	94 0.4×	187 0.8×	137	1.7k
Jae‐Hun Kim South Korea	34	347 0.8×	124 0.4×	81 0.3×	289 1.1×	41 0.2×	177	3.9k
Thomas Vogel United States	27	892 2.0×	168 0.5×	54 0.2×	531 2.1×	168 0.7×	77	2.4k
Yoichi Suzuki Japan	30	1.4k 3.2×	60 0.2×	268 1.0×	334 1.3×	158 0.7×	113	2.9k
Akira Wada Japan	25	537 1.2×	238 0.7×	69 0.3×	50 0.2×	440 1.9×	195	2.4k
Stephen J. Beebe United States	47	2.4k 5.3×	219 0.6×	139 0.5×	224 0.9×	1.0k 4.4×	142	8.7k
Kosuke Saito Japan	27	947 2.1×	115 0.3×	115 0.4×	204 0.8×	88 0.4×	154	2.2k

Countries citing papers authored by David W. Porter

Since Specialization

Citations

This map shows the geographic impact of David W. Porter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David W. Porter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David W. Porter more than expected).

Fields of papers citing papers by David W. Porter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David W. Porter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David W. Porter. The network helps show where David W. Porter may publish in the future.

Co-authorship network of co-authors of David W. Porter

This figure shows the co-authorship network connecting the top 25 collaborators of David W. Porter. A scholar is included among the top collaborators of David W. Porter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David W. Porter. David W. Porter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lang, Stuart, Daniel A. Fletcher, Paul K. Fyfe, et al.. (2024). Application of an NMR/Crystallography Fragment Screening Platform for the Assessment and Rapid Discovery of New HIV‐CA Binding Fragments. ChemMedChem. 19(13). e202400025–e202400025.

Mullen, Lisa A., et al.. (2023). Breast cancer detection with upstream data fusion, machine learning, and automated registration: initial results. Journal of Medical Imaging. 10(S2). S22409–S22409.

Heap, Rachel E., Anthony G. Hope, Kathleen M. S. E. Reyskens, et al.. (2017). Identifying Inhibitors of Inflammation: A Novel High-Throughput MALDI-TOF Screening Assay for Salt-Inducible Kinases (SIKs). SLAS DISCOVERY. 22(10). 1193–1202. 41 indexed citations

Douglas, Alexander D., Nick J. Edwards, C.J. Duncan, et al.. (2013). Comparison of Modeling Methods to Determine Liver-to-blood Inocula and Parasite Multiplication Rates During Controlled Human Malaria Infection. The Journal of Infectious Diseases. 208(2). 340–345. 31 indexed citations

Porter, David W., Zarin Brown, Steven J. Charlton, et al.. (2013). The discovery of potent, orally bioavailable pyrazolo and triazolopyrimidine CXCR2 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 24(1). 72–76. 17 indexed citations

Porter, David W., et al.. (2012). Chemo- and enantioselective Rh-catalysed hydrogenation of 3-methylene-1,2-diazetidines: application to vicinal diamine synthesis. Chemical Communications. 48(79). 9852–9852. 8 indexed citations

Moffett, R. Charlotte, et al.. (2012). Effects of glucose-dependent insulinotropic polypeptide receptor knockout and a high-fat diet on cognitive function and hippocampal gene expression in mice. Molecular Medicine Reports. 12(1). 1544–1548. 23 indexed citations

Porter, David W., et al.. (2012). (Val⁸)GLP‐1‐Glu‐PAL: a GLP‐1 Agonist That Improves Hippocampal Neurogenesis, Glucose Homeostasis, and β‐Cell Function in High‐Fat‐Fed Mice. ChemMedChem. 8(4). 595–602. 27 indexed citations

Porter, David W., Fiona M. Thompson, Tamara Berthoud, et al.. (2011). A human Phase I/IIa malaria challenge trial of a polyprotein malaria vaccine. Vaccine. 29(43). 7514–7522. 39 indexed citations

10.

Gault, Victor A., David W. Porter, Nigel Irwin, & Peter R. Flatt. (2011). Comparison of sub-chronic metabolic effects of stable forms of naturally occurring GIP(1-30) and GIP(1-42) in high fat fed mice. Journal of Endocrinology. 208(3). 265–71. 60 indexed citations

11.

Porter, David W., Barry D. Kerr, Peter R. Flatt, Christian Hölscher, & Victor A. Gault. (2010). Four weeks administration of Liraglutide improves memory and learning as well as glycaemic control in mice with high fat dietary‐induced obesity and insulin resistance. Diabetes Obesity and Metabolism. 12(10). 891–899. 135 indexed citations

12.

Porter, David W., Nigel Irwin, Peter R. Flatt, Christian Hölscher, & Victor A. Gault. (2010). Prolonged GIP receptor activation improves cognitive function, hippocampal synaptic plasticity and glucose homeostasis in high-fat fed mice. European Journal of Pharmacology. 650(2-3). 688–693. 70 indexed citations

13.

Todryk, Stephen, Ansar A. Pathan, Sheila M. Keating, et al.. (2009). The relationship between human effector and memory T cells measured by ex vivo and cultured ELISPOT following recent and distal priming. Immunology. 128(1). 83–91. 64 indexed citations

14.

Todryk, Stephen, Michael Walther, Philip Bejon, et al.. (2009). Multiple functions of human T cells generated by experimental malaria challenge. European Journal of Immunology. 39(11). 3042–3051. 20 indexed citations

15.

Berthoud, Tamara, Helen A. Fletcher, David W. Porter, et al.. (2009). Comparing human T cell and NK cell responses in viral-based malaria vaccine trials. Vaccine. 28(1). 21–27. 13 indexed citations

16.

Thompson, Fiona M., David W. Porter, Shinji L. Okitsu, et al.. (2008). Evidence of Blood Stage Efficacy with a Virosomal Malaria Vaccine in a Phase IIa Clinical Trial. PLoS ONE. 3(1). e1493–e1493. 83 indexed citations

17.

Courtney, Stephen M., Richard T. Buck, David W. Porter, et al.. (2004). 2,3-Dihydro-1,3-dioxo-1H-isoindole-5-carboxylic acid derivatives: a novel class of small molecule heparanase inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(12). 3269–3273. 42 indexed citations

18.

Orchard, Michael G., Andrew N. Carr, David W. Porter, et al.. (2004). Rhodanine-3-acetic acid derivatives as inhibitors of fungal protein mannosyl transferase 1 (PMT1). Bioorganic & Medicinal Chemistry Letters. 14(15). 3975–3978. 107 indexed citations

19.

Hermet, Jean‐Paul R., Matthew J. McGrath, Peter O’Brien, David W. Porter, & John P. Gilday. (2004). Concise asymmetric synthesis of (−)-sparteine. Chemical Communications. 1830–1831. 34 indexed citations

20.

Hermet, Jean‐Paul R., David W. Porter, Justin R. Harrison, et al.. (2003). Synthesis of sparteine-like chiral diamines and evaluation in the enantioselective lithiation–substitution of N-(tert-butoxycarbonyl)pyrrolidine. Organic & Biomolecular Chemistry. 1(22). 3977–3988. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact